Dr Snape wrote to Dr Lane: "a significant number of HTLV-III Christmas disease patients, treated only with NHS IX and with no other risk factors, argues strongly for haste with manufacture of heated factor IX."

Chronology Information

Date:

Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Terry J Snape
Dr Richard S Lane